BCHE Knockout HAP1 Cell Line

The choice depends on whether you are studying BCHE (butyrylcholinesterase, pseudocholinesterase)'s role as the principal hepatic serum cholinesterase or modeling its applications in toxicology and emerging therapeutic uses. The Knockout line is the standard tool for asking whether BCHE is required for these processes — BCHE is a serum esterase (synthesized in liver, secreted into serum) closely related to acetylcholinesterase (AChE); BCHE hydrolyzes choline esters with broad substrate specificity, including succinylcholine (suxamethonium) — patients with BCHE deficiency experience prolonged neuromuscular blockade with this anesthetic; BCHE also hydrolyzes cocaine, mivacurium, and is an emerging therapy for cocaine overdose and organophosphate poisoning. Overexpression is useful for studying BCHE gain-of-function effects. For pharmacology and toxicology research, the EDITGENE BCHE Knockout in HAP1 enables study of BCHE biology. Rescue with wild-type, catalytically-dead, or 'atypical' (D70G — pseudocholinesterase deficiency variant causing suxamethonium sensitivity) BCHE enables structure-function studies. The knockout is valuable for studying BCHE biology, pseudocholinesterase deficiency, cocaine pharmacology (BCHE-based cocaine hydrolysis therapy), and emerging BCHE-based organophosphate antidote development.

Primary applications: • Choline ester hydrolysis: butyrylcholine, succinylcholine, cocaine hydrolysis activity analysis in BCHE-null cells. • Pseudocholinesterase deficiency modeling: rescue with D70G atypical BCHE variant for suxamethonium sensitivity studies. • Cocaine pharmacology: emerging BCHE-based cocaine hydrolysis therapy mechanism studies. • Organophosphate antidote: BCHE-based scavenger therapy for organophosphate poisoning research. EDITGENE recommends this model for researchers investigating pseudocholinesterase biology, anesthesia pharmacogenomics, and emerging BCHE-based therapeutic development.

Yes. BCHE rescue experiments require attention to secreted enzyme processing: • Construct design: use a codon-modified BCHE sequence with a small N-terminal tag (FLAG, HA, after signal peptide) — BCHE is a secreted enzyme processed from a signal peptide-containing precursor; C-terminal tag may affect secretion or tetramerization. • Secretion validation: confirm conditioned media BCHE activity by butyrylthiocholine hydrolysis. • Catalytically-dead rescue: S198A in the catalytic serine triad abolishes esterase activity. • Atypical variant rescue: D70G atypical variant enables pseudocholinesterase deficiency modeling. • Functional readout: rescue should restore butyrylcholine hydrolysis activity. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.